Add-on angiotensin receptor blockade with maximized ACE inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Add-on angiotensin receptor blockade with maximized ACE inhibition

Published:2001-06 Issue:6 Volume:59 Page:2282-2289
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Agarwal Rajiv

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease: Modification of Diet in Renal Disease Study Group;Klahr;N Engl J Med,1994

2. Blood pressure control, proteinuria, and the progression of renal disease: The modification of diet in renal disease study;Peterson;Ann Intern Med,1995

3. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy: The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia);Anonymous;Lancet,1997

4. Angiotensin receptors and their antagonists;Goodfriend;N Engl J Med,1996

5. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure;Ligtenberg;N Engl J Med,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease;Cochrane Database of Systematic Reviews;2023-07-19

3. Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease;Medicine;2021-09-03

4. Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience;Medicina;2021-06-08

5. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3